13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SC Filed 2021-02-04 Event — SEC 0001193125-21-028894 →

Frazier Life Sciences VIII, L.P. Aptinyx Inc.

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
8 13D/G filings on this issuer
7 other filings besides this one
Filer Track Record
12 filings by this filer
11 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Other 13D/G Filings on Aptinyx Inc.

FiledFormFilerStakeShares
2023-03-16 SC Longitude Capital Partners II, LLC view →
2022-02-11 SC New Leaf Ventures III, L.P. view →
2021-05-04 SC Frazier Life Sciences VIII, L.P. view →
2021-03-26 SC Bain Capital Life Sciences Fund, L.P. view →
2020-10-27 SC Bain Capital Life Sciences Fund, L.P. view →
2020-01-16 SC Frazier Life Sciences VIII, L.P. view →
2020-01-16 SC Bain Capital Life Sciences Fund, L.P. view →

Other Filings by Frazier Life Sciences VIII, L.P.

FiledFormIssuerStakeShares
2023-10-26 SC Arcutis Biotherapeutics, Inc. ARQT view →
2022-02-15 SC ALPINE IMMUNE SCIENCES, INC. view →
2021-09-21 SC ALPINE IMMUNE SCIENCES, INC. view →
2021-05-12 SC Arcutis Biotherapeutics, Inc. ARQT view →
2021-05-04 SC Aptinyx Inc. view →
2021-02-09 SC Arcutis Biotherapeutics, Inc. ARQT view →
2020-04-29 SC Sierra Oncology, Inc. view →
2020-03-23 SC Entasis Therapeutics Holdings Inc. view →
2020-01-16 SC Aptinyx Inc. view →
2020-01-13 SC Entasis Therapeutics Holdings Inc. view →
2019-01-23 SC ALPINE IMMUNE SCIENCES, INC. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →